[HTML][HTML] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, G Cuyun Carter, U Kiiskinen… - BMC cancer, 2019 - Springer
Background Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
[PDF][PDF] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter, U Kiiskinen… - 2019 - academia.edu
Background: Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter… - BMC …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter, U Kiiskinen… - BMC …, 2019 - search.proquest.com
Background Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
AD Vickers, KB Winfree, U Kiiskinen, MH Jen, D Stull… - BMC Cancer, 2019 - europepmc.org
Background Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
[引用][C] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter, U Kiiskinen… - BMC Cancer, 2019 - cir.nii.ac.jp
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer:
a systematic review and network meta-analysis | CiNii Research CiNii 国立情報学研究所 …
a systematic review and network meta-analysis | CiNii Research CiNii 国立情報学研究所 …
[HTML][HTML] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, G Cuyun Carter… - BMC …, 2019 - bmccancer.biomedcentral.com
Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has progressed
after first-line treatment has a poor prognosis. Recent randomized clinical trials (RCTs) have …
after first-line treatment has a poor prognosis. Recent randomized clinical trials (RCTs) have …
Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.
AD Vickers, KB Winfree, G Cuyun Carter… - BMC …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> Locally advanced or metastatic non-small
cell lung cancer (NSCLC) that has progressed after first-line treatment has a poor prognosis …
cell lung cancer (NSCLC) that has progressed after first-line treatment has a poor prognosis …
[HTML][HTML] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter, U Kiiskinen… - BMC Cancer, 2019 - ncbi.nlm.nih.gov
Background Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
[PDF][PDF] Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis
AD Vickers, KB Winfree, GC Carter, U Kiiskinen… - 2019 - kimia-pharma.co
Background: Locally advanced or metastatic non-small cell lung cancer (NSCLC) that has
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …
progressed after first-line treatment has a poor prognosis. Recent randomized clinical trials …